Retinal Disease
122
21
27
54
Key Insights
Highlights
Success Rate
79% trial completion
Published Results
17 trials with published results (14%)
Research Maturity
54 completed trials (44% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.5%
14 terminated out of 122 trials
79.4%
-7.2% vs benchmark
8%
10 trials in Phase 3/4
31%
17 of 54 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 54 completed trials
Clinical Trials (122)
National Eye Institute Biorepository for Retinal Diseases
Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene
A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular Edema
Cell Collection to Study Eye Diseases
Modified Soft Contact Lens During Vitrectomy
Study to Evaluate the Long-Term Safety of Ultevursen in Participants With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene
Smartphone Screening for Eye Diseases
Optimize Pediatric OCT Imaging
Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene
Stem Cell Ophthalmology Treatment Study II
Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
The Genetics Navigator: Evaluating a Digital Platform for Genomics Health Services
P200TxE Diseased Eye Image Collection
AI-Assisted Interpretation of Ultra-Widefield Retinal Images
Collecting Data on Retinal Blood Blood Flow and Blood Vessel Shape/Appearance Using an Investigational Device, XyCAM CRE, and to Then Compare Those Images With Images Collected From a Patient's Routine Clinical Examination.
Establishment of a Multimodal Standard Database for Inflammation-related Ophthalmopathy
A Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001 Administered Intravitreally in Participants With Confirmed PRPF31 Mutation-Associated Retinal Dystrophy, Including Participants Previously Treated With VP001
MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby)
Inherited Retinal Degenerative Disease Registry
COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Inherited Retinal Disease